How Alzheimer’s Villages Are Helping Mitigate the Effects of Dementia

Dembitzer - Charting New Roads - Dementia Village

In a fascinating medical/social initiative, the Village Landais Alzheimer (Landes Alzheimer’s Village) in France took in 105 individuals with early to late-stage Alzheimer’s to study whether having them grouped together in a micro-village setting could help ease symptoms of the disease. The project, which is ongoing from 2020 until 2025, aims to provide better care … Read more

Why The Northern Charitable Foundation Sponsors the Prevention GENEration Program

Rosa Dembitzer - Breast cancer awareness month

We are very passionate about sponsoring the Israel Cancer Association’s Prevention GENEration Program in collaboration with The Israel Hereditary Breast and Ovarian Cancer Consortium. The aim of the program is to reduce cancer morbidity in Israel by promoting research, prevention, early detection, treatment modalities, and means of rehabilitation. The High Rate of Individuals with the … Read more

Looking Towards the Future: WHO Reports Alarming Increase in Dementia and Worrisome Projections

Charting New Roads - Increase in rates of Dementia

As the Baby Boom generation ages, the World Health Organization (WHO) has reported a significant increase in cases of dementia. There were some 55 million cases of dementia reported worldwide in 2019, and the WHO predicts that by 2030, that number could reach approximately 78 million, an increase of  42%. The WHO went even further … Read more

New Studies Show Cleaner Air Could Lower Susceptibility to Dementia

Northern Charitable Foundation - Dementia and air pollution

New research was presented at the 2021 Alzheimer’s Association International Conference (AAIC) showing that cleaner air could reduce an individual’s risk of developing dementia. This follows research indicating that there could be a link between air pollution and the risk of developing dementia, specifically Alzheimer’s disease. One study was funded by the National Institutes of … Read more

New Parp Inhibitor Lynparza May Be Important Tool for Treating Early-Stage Breast Cancer

Northern Charitable Foundation - breast cancer research

The President of the American Society for Clinical Oncology shared that new research has found that the Lynparza parp inhibitor could have a significant impact on the treatment and decision paths of patients with both high-risk and early-stage breast cancer. The study also showed that Lynparza reduces the chances that patients with the BRCA gene … Read more